Close



Apr 17, 2024 04:06PM
Apr 17, 2024 04:05PM
Mar 7, 2024 04:05PM
Mar 1, 2024 08:31AM
Mar 1, 2024 08:30AM
Jan 16, 2024 05:36PM
Jan 16, 2024 05:28PM Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 Guidance
Nov 6, 2023 08:51AM
Nov 6, 2023 08:45AM
Aug 8, 2023 08:46AM
Aug 8, 2023 08:45AM
Jun 22, 2023 08:46AM
Jun 22, 2023 08:45AM
Jun 8, 2023 04:05PM Evolus Reaches 1 Million Redemptions in its Evolus Rewards™ Patient Loyalty Program
Jan 29, 2023 06:34PM
Jan 28, 2023 08:00AM
Jan 23, 2023 08:00AM
Aug 24, 2022 08:15AM
Aug 24, 2022 08:14AM
Jul 19, 2022 08:37AM
Jul 12, 2022 08:47AM Evolus Successfully Completes Patient Enrollment in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®
Jun 2, 2022 08:55AM
Jun 2, 2022 08:54AM
May 18, 2022 08:15AM
May 11, 2022 08:45AM
May 10, 2022 04:05PM
Apr 26, 2022 08:45AM
Mar 31, 2022 08:15AM Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®
Mar 8, 2022 08:45AM
Mar 3, 2022 04:05PM
Mar 3, 2022 04:05PM
Mar 3, 2022 04:05PM
Mar 1, 2022 08:45AM
Feb 17, 2022 08:45AM
Feb 8, 2022 08:47AM Evolus (EOLS) Announces Acceptance of Submission in Australia
Feb 8, 2022 08:45AM
Feb 2, 2022 09:15AM
Jan 26, 2022 08:45AM
Jan 26, 2022 08:45AM
Jan 5, 2022 08:46AM
Jan 5, 2022 08:45AM
Dec 20, 2021 08:45AM Evolus Joins Nasdaq Biotechnology Index
Dec 14, 2021 08:45AM
Nov 9, 2021 08:30AM
Nov 2, 2021 08:03AM
Nov 2, 2021 08:01AM
Nov 1, 2021 04:10PM
Oct 22, 2021 09:00AM
Sep 2, 2021 09:00AM Evolus Announces Participation in September Investment Conferences
Aug 4, 2021 04:05PM

251,370 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All